Trump Administration Targets Peptide Market Amid FDA Regulatory Shifts

The peptide market is expanding rapidly as the FDA considers loosening restrictions on these compounds. Doctors are issuing warnings about the 'Wild West' nature of the industry, highlighting the need for safe usage protocols. This development underscores the tension between emerging biotech innovations and necessary regulatory oversight.